コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 A expression of VASP (vasodilator-stimulated phosphoprotein).
2 1 and inactivation of vasodilator-stimulated phosphoprotein.
3 e, and phosphorylated vasodilator-stimulated phosphoprotein.
4 nds to the nucleocapsid template through the phosphoprotein.
5 acid analysis, we show that yeast MIPS is a phosphoprotein.
6 rotubule-associated protein tau is an axonal phosphoprotein.
7 d mass spectrometry analysis of the enriched phosphoproteins.
8 , respectively, both the PSII core and LHCII phosphoproteins.
9 ifically bind to the phosphate groups on any phosphoproteins.
10 tion, which requires effective enrichment of phosphoproteins.
11 e than 11,000 phosphorylation sites in 2,500 phosphoproteins.
12 by general methods to biosynthesize defined phosphoproteins.
13 olding and thereby activity and stability of phosphoproteins.
14 rotein 79 (AKAP79) delineates PP2B access to phosphoproteins.
15 orylation in both phosphopeptides and intact phosphoproteins.
16 enic markers, alkaline phosphatase, secreted phosphoprotein 1 (osteopontin), and bone gamma-carboxygl
18 s SNPs associated with Src kinase-associated phosphoprotein 1 (SKAP1), matrix metallopeptidase 12 (MM
23 PGC-1alpha induces the secretion of secreted phosphoprotein 1 and the recruitment of macrophages.
25 ontrast, induction of PGC-1alpha in secreted phosphoprotein 1(-/-) mice leads to immature capillariza
26 Pb induced the expression of SPP1 (secreted phosphoprotein 1), which has known neuroprotective effec
32 lls gain metastatic capacity through a Golgi phosphoprotein 3-dependent (GOLPH3-dependent) Golgi memb
33 cAMP], dopamine- and cAMP-regulated neuronal phosphoprotein 32 kDa [DARPP-32], and cAMP responsive el
36 that the scaffolding protein, ezrin-binding phosphoprotein 50 (EBP50), is a central regulator of mac
38 adaptor protein named Src kinase-associated phosphoprotein 55 homologue (SKAP-Hom) as a novel substr
39 and CD8(+) CMV-specific memory responses to phosphoprotein 65 (pp65) in a prospective cohort of 18 D
41 cytomegalovirus (HCMV) is the immunodominant phosphoprotein 65 (pp65), which is frequently included i
42 correlated with granzyme B loading, and CMV phosphoprotein 65 (pp65)-specific CD8(+)IFN-gamma(+) and
44 significantly rescued, most effectively with phosphoprotein 65 Ag and combined exogenous IL-2 and IL-
45 -specific CTLs responded specifically to CMV-phosphoprotein 65 stimulation by secreting IFN-gamma and
46 e early 1 or 100 spots per 250 000 cells for phosphoprotein 65) identified patients who were protecte
48 hort that were specific for epitopes of HCMV phosphoprotein-65, tetanus toxoid precursor, EBV nuclear
49 ent of maize leaves, we analyzed protein and phosphoprotein abundance as maize leaves transition from
50 dence that lack of secretory calcium-binding phosphoproteins accounts for the evolutionary loss of sc
53 ids followed by quantitative phenotyping and phosphoprotein analyses uncover key changes in the signa
58 nt protein (EGFP) was introduced between the phosphoprotein and matrix genes (position 5) of the geno
62 ficant challenge due to the low abundance of phosphoproteins and the low stoichiometry of phosphoryla
66 ay in Dajiao, along with other cold-specific phosphoproteins, appears to be associated with the molec
70 zation from synapses, thereby indicating the phosphoprotein as a novel target through which S1P contr
73 tance aggregometry or vasodilator-stimulated phosphoprotein assays, was numerically but not significa
74 proteins, can reinvigorate studies of 14-3-3/phosphoprotein assemblies, including those with challeng
75 binding to a transmembrane adaptor known as phosphoprotein associated with glycosphingolipid-enriche
77 antigen (Sjogren's syndrome antigen B) is a phosphoprotein associated with nascent precursor tRNAs a
81 nhibition was abolished by truncation of the phosphoprotein-binding Breast Cancer 1 C-terminal domain
84 ic screens have revealed many Rab GTPases as phosphoproteins, but the effects of this modification ar
85 Pin1 regulates the levels and functions of phosphoproteins by catalyzing phosphorylation-dependent
86 rom a recombinant baculovirus vector and the phosphoprotein cofactor (P) in Escherichia coli and puri
89 atform for direct expression of programmable phosphoproteins containing multiple phosphorylated resid
90 ecline in G-actin; reduced cofilin and HSP27 phosphoprotein content, respectively; and blocked the my
92 e assigned all phosphorylation sites to 3013 phosphoproteins, covering the entire dynamic range from
93 are altogether 47 923 phosphosites in 16 477 phosphoproteins curated across nine plant organisms from
94 ion of dopamine- and cAMP-regulated neuronal phosphoprotein (DARPP-32) exclusively in D2R-expressing
95 rons expressing dopamine- and cAMP-regulated phosphoprotein (DARPP-32+), known to be modulated by dop
99 ublished pseudopodium-enriched (PDE) protein/phosphoprotein datasets to identify novel PDAC-specific
105 hat neuronal levels of the survival protein, phosphoprotein enriched in astrocytes at approximately 1
107 gel electrophoresis, as well as column-based phosphoprotein enrichment followed by liquid chromatogra
108 we performed and compared phosphopeptide and phosphoprotein enrichment methodologies after activation
114 th the phosphoprotein-specific Pro-Q Diamond phosphoprotein fluorescent stain and chemical dephosphor
115 ssociations involving vasodilator-stimulated phosphoprotein, focal adhesion kinase, and protein-disul
116 ssociations involving vasodilator-stimulated phosphoprotein, focal adhesion kinase, the H(+)/K(+) ATP
117 rosylation, including vasodilator-stimulated phosphoprotein, focal adhesion kinase, the membrane phos
119 mmunization with rBCG strains expressing the phosphoprotein from hMPV also can induce protective Th1
120 ated RABV expressing the glycoprotein or the phosphoprotein from wt RABV) demonstrate that DC activat
122 tative phosphoproteomics analysis, isolating phosphoproteins from whole brain derived from E18.5 Cdk5
123 identical to those of the nucleoprotein and phosphoprotein genes except that it contains an apparent
125 RNAs), 17,862 nonmodified proteins, and 6227 phosphoproteins harboring 31,595 phosphorylation sites q
129 minal EVH1 (Ena/VASP [vasodilator-stimulated phosphoprotein] homology domain 1) binding domains of Lp
131 Here, we provide evidence that MKP1 is a phosphoprotein in vivo and that MKP1 accumulates in resp
133 k of genes encoding secreted calcium-binding phosphoproteins in cartilaginous fishes explains the abs
134 al phosphorylation dynamics of 1,887 cardiac phosphoproteins in early affected heart tissue in a tran
136 the level of 133 key signaling proteins and phosphoproteins in laser capture microdissected (LCM) pr
137 of cocaine-induced dephosphorylation of key phosphoproteins in the prefrontal cortex related to syna
138 e for phosvitin, an intrinsically disordered phosphoprotein, in chick embryo skeletal development, an
140 at draws on biophysical data from SH2 domain-phosphoprotein interactions to predict the functional ef
143 study, we identify Synapsin I, a presynaptic phosphoprotein involved in the control of availability o
149 hment of pY-containing peptides derived from phosphoproteins is commonly facilitated by use of immobi
150 esized that nucleophosmin (NPM), a nucleolar phosphoprotein, is critical for Bax-mediated cell death.
151 (GAP43), a protein kinase C (PKC)-activated phosphoprotein, is often implicated in axonal plasticity
153 with the v-ATPase and the associated LAMTOR1 phosphoprotein, key components of the lysosomal nutrient
155 RGS9-2 affects several protein interactions, phosphoprotein levels, and the function of the epigeneti
156 sessments measured by vasodilator-stimulated phosphoprotein, light transmittance aggregometry, and Mu
157 ding VerifyNow P2Y12, vasodilator-stimulated phosphoprotein, light transmittance aggregometry, and Mu
159 and cyclic adenosine monophosphate-regulated phosphoprotein, Mr 32000) in promoting tumor growth thro
160 We previously identified the centrosomal phosphoprotein NDE1 as a negative regulator of ciliary l
164 hat Bcl-2 binds dopamine- and cAMP-regulated phosphoprotein of 32 kDa (DARPP-32), a protein kinase A
165 lling, dopamine- and cAMP-regulated neuronal phosphoprotein of 32 kDa feedback, and synaptic plastici
167 ated apical scaffolding proteins ERM-binding phosphoprotein of 50 kDa (EBP50) and NHE3 kinase A regul
168 n Src homology 2 domain-containing leukocyte phosphoprotein of 76 kDa (SLP-76) plays a crucial role i
184 al polymerase L in complex with its cofactor phosphoprotein (P) binds the nucleocapsid that constitut
185 otein is the main catalytic subunit, and the phosphoprotein (P) is an essential cofactor for polymera
192 nucleocapsid protein (N) and associated by a phosphoprotein (P) with the large polymerase protein (L)
193 lysis in HEp-2 cells, the nucleoprotein (N), phosphoprotein (P), matrix protein (M), and fusion prote
194 s were discovered, including epitopes in the phosphoprotein (P), polymerase protein (L), M2-1 protein
195 polymerase protein (L) and its cofactor, the phosphoprotein (P), which associate with the viral ribon
200 ical enrichment analysis of the differential phosphoprotein patterns revealed selective perturbation
202 als PP5 utilization of conserved elements of phosphoprotein phosphatase (PPP) structure to bind subst
204 18 and 24 months following control, BDNF or phosphoprotein phosphatase 1 derivative (1NMPP1) treatme
209 rn of evolution of eukaryotic bacterial-like phosphoprotein phosphatase sequences, which are predomin
211 Kelch-like domains (PPKL) are members of the phosphoprotein phosphatases family present only in plant
212 nchoring proteins direct protein kinases and phosphoprotein phosphatases toward selected substrates t
214 ar Pi concentration, which directly inhibits phosphoprotein phosphatases, triggering a global increas
215 ynaptic expression of vasodilator-stimulated phosphoprotein phospho-mimetic or phospho-resistant muta
218 12 reaction units and vasodilator-stimulated phosphoprotein phosphorylation and platelet reactivity i
220 let reactivity index (vasodilator-stimulated phosphoprotein phosphorylation assay) at baseline (befor
224 onfirmed by increased vasodilator-stimulated phosphoprotein phosphorylation in MRP4-deficient platele
227 ation, p = 0.005) and vasodilator-stimulated phosphoprotein platelet reactivity index (20.7% relative
228 as well as changes in vasodilator-stimulated phosphoprotein platelet reactivity index and P-selectin
229 APTITUDE-CABG) study, vasodilator-stimulated phosphoprotein-platelet reactivity index, a specific mar
230 eal-time polymerase chain reaction (qPCR) or phosphoprotein (pp65) antigenemia (pp65emia) for startin
234 s a member of the Ena/vasodilator-stimulated phosphoprotein protein family, which facilitates the ass
235 demonstrates that proteins and particularly phosphoproteins provide information for predicting drug
238 pd and the host VASP (vasodilator-stimulated phosphoprotein) recruited to the bacterial cell surface
239 MN), a cytoplasmic microtubule-destabilizing phosphoprotein, regulates interphase microtubules during
240 he role of Synapsin, a conserved presynaptic phosphoprotein regulating the balance between the reserv
241 re epilepsy susceptibility genes that encode phosphoproteins reversibly associated with synaptic vesi
243 We also identify new interactions between phosphoprotein signaling and cellular energy processes t
247 onal electrophoresis in combination with the phosphoprotein-specific Pro-Q Diamond phosphoprotein flu
248 ity as confirmed by SDS-PAGE analysis with a phosphoprotein-specific stain and mass spectrometry anal
252 size several phosphoproteins and demonstrate phosphoprotein structure determination and synthetic pro
256 a functional complex with the SV-associated phosphoprotein synapsin, previously implicated in SV clu
258 ribution of Synapsin I (SynI), a presynaptic phosphoprotein that controls the availability of synapti
259 d by phospholamban (PLB), a small inhibitory phosphoprotein that decreases the Ca(2+) affinity of SER
261 t PC1 interacts with Pacsin 2, a cytoplasmic phosphoprotein that has been implicated in cytoskeletal
263 Synapsin III (SynIII) is a neuron-specific phosphoprotein that plays a unique role in neuronal deve
264 s (HCV) nonstructural protein 5A (NS5A) is a phosphoprotein that plays key, yet poorly defined, roles
266 re associated with deficiency of synapsin, a phosphoprotein that reversibly associates with synaptic
267 s in alpha-casein, an approximately 23.5 kDa phosphoprotein that showed eight of nine known phosphory
268 , we show that alpha-arrestin Aly1/Art6 is a phosphoprotein that specifically interacts with and is d
271 napsin family of synaptic vesicle-associated phosphoproteins that is precociously expressed in neuron
272 tabolites, associated metabolic enzymes, and phosphoproteins, the resultant data provided input for a
273 As synapsin is a synaptic vesicle-clustering phosphoprotein, these observations identify a presynapti
274 capture, enrichment, and detection of intact phosphoproteins toward a comprehensive analysis of the p
277 th the average number of predictor genes per phosphoprotein used by the teams ranging from 3 to 124.
282 to determine whether vasodilator-stimulated phosphoprotein (VASP) signaling improves lipid metabolis
283 age overexpression of vasodilator-stimulated phosphoprotein (VASP), a key downstream mediator of intr
286 y member A (RhoA) and vasodilator-stimulated phosphoprotein was increased in response to 8-CPT-cGMP t
287 147 microenvironment and the CD147-dependent phosphoproteins was generated and led to the identificat
289 total of 1,953 mRNAs, 187 proteins, and 131 phosphoproteins were differentially expressed (DE) betwe
290 phosphopeptides belonging to 3163 different phosphoproteins were efficiently identified with high-th
295 a conducive environment for introduction of phosphoproteins while simultaneously modulating the spre
297 f nucleophosmin (NPM/B23), a major nucleolar phosphoprotein with diverse cellular activities linked t
298 ofiling identified a set of PfCRK4-regulated phosphoproteins with greatest functional similarity to C
299 Ping) through coupling specific detection of phosphoproteins with protein identification and phosphor
300 is a bi-phasic system containing lipids and phosphoproteins, working synergistically to maximize adh
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。